BEAM vs HUBS · rev $32.2M vs P/E 96, rev $1.79B
Beam Therapeutics Inc (BEAM) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported BEAM revenue for 2026-06-30 was $32.2M. Net income was -$217.0M. Revenue was up 1.5% from 2026-03-31 to 2026-06-30. BEAM currently screens at market cap $2.01B.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
BEAM currently screens at market cap $2.01B. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the BEAM and HUBS stock pages for the full models.
Not investment advice.